Skip to main content

Table 2 Treatment and follow-up of patients with primary non-Hodgkin’s lymphoma of the breast

From: Primary malignant non-Hodgkin’s lymphoma of the breast: a study of seven cases and literature review

Case no.

Age/sex

Size of tumor (cm)

Site of tumor

Clinical information

Ipsilateral lymph nodes

Histology

Ann/Arbor

IPI

1

32/F

3

Left lower outer quadrant

Palpable mass

Present

DLBCL

IIBE

1

2

38/F

7

Left

Palpable mass

Absent

DLBCL

IBE

1

3

47/F

4

Right upper outer quadrant

Palpable mass

Present

DLBCL

IIAE

2

4

60/F

4

Right upper outer quadrant

Palpable mass

Absent

DLBCL

IBE

2

5

55/F

-

Left

Palpable mass

--

DLBCL

IBE

2

6

45/F

5 right/3 left

Bilateral

Palpable masses in both breasts

Present (bilateral)

DLBCL

IIAE

4

7

76/M

-

Left

Palpable lumps

Absent

DLBCL

IBE

1

  1. CHOP cyclophosphamide, doxorubicin, vincristine, prednisone; R rituximab; ICE ifosfamide, carboplatin and etoposide; CR complete remission; AW alive and well.